Ranibizumab for neovascular age-related macular degeneration.
Publication
, Journal Article
Gillies, MC; Wong, TY
Published in: N Engl J Med
February 15, 2007
Duke Scholars
Published In
N Engl J Med
EISSN
1533-4406
Publication Date
February 15, 2007
Volume
356
Issue
7
Start / End Page
748 / 749
Location
United States
Related Subject Headings
- Vascular Endothelial Growth Factor A
- Ranibizumab
- Male
- Macular Degeneration
- Humans
- Hemorrhage
- General & Internal Medicine
- Female
- Antibodies, Monoclonal, Humanized
- Antibodies, Monoclonal
Citation
APA
Chicago
ICMJE
MLA
NLM
Gillies, M. C., & Wong, T. Y. (2007). Ranibizumab for neovascular age-related macular degeneration. N Engl J Med, 356(7), 748–749.
Gillies, Mark C., and Tien Y. Wong. “Ranibizumab for neovascular age-related macular degeneration.” N Engl J Med 356, no. 7 (February 15, 2007): 748–49.
Gillies MC, Wong TY. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2007 Feb 15;356(7):748–9.
Gillies, Mark C., and Tien Y. Wong. “Ranibizumab for neovascular age-related macular degeneration.” N Engl J Med, vol. 356, no. 7, Feb. 2007, pp. 748–49.
Gillies MC, Wong TY. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2007 Feb 15;356(7):748–749.
Published In
N Engl J Med
EISSN
1533-4406
Publication Date
February 15, 2007
Volume
356
Issue
7
Start / End Page
748 / 749
Location
United States
Related Subject Headings
- Vascular Endothelial Growth Factor A
- Ranibizumab
- Male
- Macular Degeneration
- Humans
- Hemorrhage
- General & Internal Medicine
- Female
- Antibodies, Monoclonal, Humanized
- Antibodies, Monoclonal